Who has invested in Adagio Therapeutics?

Polaris Partners, Mithril Capital, Fidelity Management & Research Company, OrbiMed, M28 Capital, GV are named among the investors backing Adagio Therapeutics.

Adagio Therapeutics Funding: $130M Raised, Series B

Adagio Therapeutics funding overview

Adagio Therapeutics has raised $130M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B. Investors on record include Polaris Partners, Mithril Capital, Fidelity Management & Research Company, OrbiMed, M28 Capital, GV and 2 others. 8 distinct backers are named across the disclosed rounds.

Adagio Therapeutics at a glance

Total raised: $130M
Latest round: Series B
Notable investors: Polaris Partners, Mithril Capital, Fidelity Management & Research Company, OrbiMed, M28 Capital, GV, Population Health Partners, Omega Funds

Frequently asked about Adagio Therapeutics funding

How much has Adagio Therapeutics raised?: Adagio Therapeutics has raised $130M in total disclosed funding across the rounds on record.
Who has invested in Adagio Therapeutics?: Polaris Partners, Mithril Capital, Fidelity Management & Research Company, OrbiMed, M28 Capital, GV are named among the investors backing Adagio Therapeutics.
What was the latest Adagio Therapeutics funding round?: The most recent disclosed round is a Series B.
Where is Adagio Therapeutics based?: No headquarters location is disclosed for Adagio Therapeutics.

We update the Adagio Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies and their backers are listed below.

Adagio Therapeutics Funding: $130M Raised, Series B

Adagio Therapeutics funding overview

Adagio Therapeutics at a glance

Frequently asked about Adagio Therapeutics funding

Companies related to Adagio Therapeutics (18)

Browse related funding lists (5)